SUBSTITUTED 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS CASEIN KINASE 1 D/E INHIBITORS

SUBSTITUTED 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS CASEIN KINASE 1 D/E INHIBITORS

The invention provides compounds of Formula (I): and pharmaceutically acceptable salts thereof. The compounds of Formula (I) inhibit protein kinase activity thereby making them useful as anticancer agents. L'invention concerne des composés de formule (I) et leurs sels pharmaceutiquement accepta...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LIU, PEIYING, REDDY, BANDREDDY SUBBA, PEARCE, BRADLEY C, BORA, RAJESH ONKARDAS, KUMARAVEL, SELVAKUMAR, DASGUPTA, BIRESHWAR, NAGALAKSHMI, PULICHARLA, MULLICK, DIBAKAR, NAIR, JALATHI SURENDRAN, JANAKIRAMAN, SAKTHI KUMARAN, RAO, METTU MALLIKARJUNA, ARAUJO, ERIKA M.V, WITTMAN, MARK D, RACHAMREDDY, CHANDRASEKHAR REDDY, KARUPPIAH, ARUL MOZHI SELVAN SUBBIAH, MAHESHWARAPPA, SHILPA HOLEHATTI, SISTLA, RAMESH, VELAPARTHI, UPENDER, DARNE, CHETAN PADMAKAR
Format: Patent
Sprache:eng ; fre
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention provides compounds of Formula (I): and pharmaceutically acceptable salts thereof. The compounds of Formula (I) inhibit protein kinase activity thereby making them useful as anticancer agents. L'invention concerne des composés de formule (I) et leurs sels pharmaceutiquement acceptables. Les composés de formule (I) inhibent l'activité protéine kinase, ce qui leur permet d'être utilisés comme agents anticancéreux.